Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.18 USD
Change Today +0.016 / 9.94%
Volume 347.4K
HEB On Other Exchanges
As of 8:04 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

William A. Carter M.D.

Chairman, Chief Executive Officer, Chief Scientific Officer, Chairman of Executive Committee, Member of Disclosure Controls Committee and Member of Strategic Planning Committee,Hemispherx Biopharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 board members in 1 different organizations across 1 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. William A. Carter, M.D. has been the Chairman, Chief Executive Officer and Chief Scientific Officer of Hemispherx Biopharma, Inc. since January 1992, July 1993 and May 1989 respectively. Dr. Carter served as President of Hemispherx Biopharma, Inc. Dr. Carter joined Hemispherx Biopharma Inc., in 1978 and served as its Chairman from 1987 to 1988 and President from April 1995 to November 2006. Dr. Carter is co-inventor of Ampligen. Dr. Carter received the first FDA ...

Read Full Background

Corporate Headquarters*

One Penn Center
Philadelphia, Pennsylvania 19103

United States

Phone: 215-988-0080
Fax: 215-988-1739

Board Members Memberships*

Chairman, Chief Executive Officer, Chief Scientific Officer, Chairman of Executive Committee, Member of Disclosure Controls Committee and Member of Strategic Planning Committee


Duke University
Post-Doctoral Training
Johns Hopkins University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,894,242

Stock Options*

All Other Compensation$153,141
Exercisable Options7,695,378
Unexercisable Options820,000
Total Number of Options8,515,378

Total Compensation*

Total Annual Cash Compensation$2,229,845
Total Short Term Compensation$1,894,242
Other Long Term Compensation$153,141
Total Calculated Compensation$2,364,875
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HEB:US $0.18 USD +0.016


Frank Mathias Chief Executive Officer and Member of Executive Board
MediGene AG
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.1M GBP
Edward M. Kaye M.D., Ph.D.Interim Chief Executive Officer, Chief Medical Officer and Senior Vice President
Sarepta Therapeutics, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HEMISPHERX BIOPHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at